Aytu Gets OK for Manufacturing Site Transfer Prior Approval Supplement

 U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to Contract Manufacturer

Upon Completion of Manufacturing Transfer of Adzenys XR-ODT and Cotempla XR-ODT, Company Expects to Report Enhanced ADHD Product Margins

https://www.biospace.com/article/releases/aytu-biopharma-announces-approval-of-the-cotempla-xr-odt-r-manufacturing-site-transfer-prior-approval-supplement/